EMEA-002052-PIP02-23 - paediatric investigation plan

deutetrabenazine
PIP Human

Key facts

Active substance
deutetrabenazine
Therapeutic area
Neurology
Decision number
P/0205/2023
PIP number
EMEA-002052-PIP02-23
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of tardive dyskinesia
Route(s) of administration
Oral use
Contact for public enquiries

Teva B.V.

E-mail: MedInfo@tevaeu.com
Tel: +44 (0)2075407117

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Compliance check done
No

Decision

Share this page